Autocrine EGF and TGF‐α promote primary and acquired resistance to ALK/c‐Met kinase inhibitors in non‐small‐cell lung cancer

Drug resistance severely limits the clinical therapeutic value of molecularly targeted drugs. Growth factors gain a tremendous amount of focus due to the ability to promote drug resistance in non‐small‐cell lung cancer (NSCLC). However, whether tumor cells themselves can mediate drug resistance by s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yueqin, Zhang, Yu, Chen, Ruiying, Tian, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801488/
https://www.ncbi.nlm.nih.gov/pubmed/36583451
http://dx.doi.org/10.1002/prp2.1047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801488/
https://www.ncbi.nlm.nih.gov/pubmed/36583451
http://dx.doi.org/10.1002/prp2.1047

Ejemplares similares